Cue Biopharma (1UC.F) Q3 2024 Earnings

19AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.26
-0.23
-0.21
-0.18

Details

Expected EPS
-0.252574
Actual EPS
-0.18041000000000001
Surprise EPS
0.07
Surprise Percent
+28.57%

Description

Cue Biopharma (1UC.F) has reported earnings of -0.18041000000000001 per share for Q3 2024.

0 Comments

Share your thoughts